ESC Premium Access

Improving Cardiovascular Function and Clinical Outcome in Diabetes Using New Guideline-Based Pharmacotherapy

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Antidiabetic Pharmacotherapy
Session type: Rapid Fire Abstracts
Date: 31 August 2020
Time: 08:30 - 08:30

Congress Session

8 presentations in this session

Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial.

Speaker: Doctor G. Ferrannini (Stockholm, SE)

Cardiovascular outcomes in patients with type 2 diabetes and reduced eGFR and albuminuria: a REWIND post hoc subgroup analysis

Speaker: Professor H. Colhoun (Edinburgh, GB)

Direct effects of canagliflozin on human myocardial redox signalling: a novel role for SGLT1 inhibition

Speaker: Doctor H. Kondo (Oxford, GB)

Impact of polyvascular disease and renal dysfunction on cardiovascular outcomes in diabetes: post hoc analyses from EMPA-REG OUTCOME

Speaker: Professor S. Verma (Toronto, CA)

Natriuretic effect of 2 weeks of dapagliflozin treatment in patients with type 2 diabetes and preserved kidney function: results of the DAPASALT trial

Speaker: Professor H. Heerspink (Groningen, NL)

The effects of empagliflozin on arterial stiffness, endothelial function and ventriculoarterial coupling in type 2 diabetes mellitus: 1 year follow up

Speaker: Doctor I. Ikonomidis (Athens, GR)

Analysis of first plus recurrent cardiovascular (CV) and hospitalisation events in the CAROLINA trial

Speaker: Professor N. Marx (Aachen, DE)

Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial

Speaker: Professor D. McGuire (Dallas, US)

8 speakers from this session

Doctor Giulia Ferrannini

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

Professor Helen Colhoun

, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Hidekazu Kondo

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
20 presentations
0 follower

Professor Hiddo Heerspink

University Medical Centre Groningen, Groningen (Netherlands (The))
5 presentations
0 follower

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)
5 presentations

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
28 presentations
1 follower

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center & Parkland Health and Hospital S, Dallas (United States of America)
18 presentations
0 follower

This platform is supported by

logo Novo Nordisk